Target species
Chickens (breeder and layer pullets).
Indications for use
Booster immunisation of breeder and layer pullets after vaccination with live vaccines against:
- Newcastle Disease virus in order to reduce egg drop linked to Newcastle Disease infection.
- Infectious Bronchitis virus in order to reduce egg drop linked to Infectious Bronchitis infection caused by the Mass41 strain.
- Avian pneumovirus in order to reduce respiratory signs linked to avian pneumovirus infection (Avian Rhinotracheitis).
Active immunisation of breeder and layer pullets in order to reduce egg drop linked to infection with Egg Drop Syndrome virus EDS76 without priming.
Newcastle Disease, Infectious Bronchitis and Egg Drop Syndrome components:
- Onset of immunity: 4 weeks after vaccination
- Duration of immunity: one laying period
Avian Rhinotracheitis component:
- Onset of immunity: 14 weeks after vaccination
- Duration of immunity: one laying period
Contra-indications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the product to animals
To the user: This veterinary medicinal product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician: This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling which may, for example, result in ischaemic necrosis and even loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Adverse reactions
No palpable reactions were observed following the injection of one dose of vaccine. Lesions linked to the oily adjuvant were histologically observed very commonly (in 87% of cases) three weeks after injection in clinical studies (e.g. small quantities of oily residues and occasional aseptic micro-abscesses).
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy, lactation or lay
Do not use in birds in lay and within 4 weeks before the start of the laying period.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Administer one dose (0.3 ml) by intramuscular route from the age of 18 weeks and at least 4 weeks after the priming with live vaccines against Newcastle Disease (strain Hitchner B1 or VG/GA), Infectious Bronchitis (strain Mass H120), and avian pneumovirus (strain PL21).
Shake well before use. Apply usual aseptic procedures. Do not use syringes with natural rubber or butyl elastomer pistons. Equipment including needles and syringes must be sterile before use.
Overdose
Transitory apathy and slight oedema at injection site may occur after the administration of a double dose of vaccine.
Withdrawal period
Zero days.